NAAA
HALO icon

New Age Alpha Advisors’s Halozyme HALO Stock Holding History

New Age Alpha Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.91M Sell
24,401
-586
-2% -$40K 0.08% 308
2026
Q1 		$1.61M Sell
24,987
-535
-2% -$37.7K 0.08% 340
2025
Q4 		$1.72M Sell
25,522
-987
-4% -$66.4K 0.07% 338
2025
Q3 		$1.94M Sell
26,509
-756
-3% -$50.2K 0.08% 310
2025
Q2 		$1.42M Buy
27,265
+1,466
+6% +$83.4K 0.06% 372
2025
Q1 		$1.65M Sell
25,799
-2,465
-9% -$143K 0.07% 347
2024
Q4 		$1.35M Buy
+28,264
New +$1.45M 0.05% 392

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

New Age Alpha Advisors's HALO Position: Q2 2026 in Review

New Age Alpha Advisors reduced its Halozyme (HALO) stake by 2.3% in Q2 2026, selling an estimated $40K and leaving 24,401 shares worth $1.91M. The position accounts for 0.08% of the portfolio, ranked #308.

New Age Alpha Advisors first reported a position in HALO in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.94M in Q3 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • New Age Alpha Advisors held 24,401 shares of Halozyme worth $1.91M as of Q2 2026.
  • New Age Alpha Advisors sold 586 Halozyme shares in Q2 2026, an estimated $40K.
  • Halozyme made up 0.08% of New Age Alpha Advisors's portfolio in Q2 2026, its #308 holding.
  • New Age Alpha Advisors first reported a position in Halozyme in Q4 2024 and has held it in 7 quarters since.
  • New Age Alpha Advisors's Halozyme position peaked at $1.94M in Q3 2025.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on New Age Alpha Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.